Prioritization of therapeutic targets of inflammation using proteomics, bioinformatics, and in silico cell-cell interactomics

Methods in Molecular Biology

Volumn 1061, Issue , 2013, Pages 345-360

  Haqqani, Arsalan S ^a   Stanimirovic, Danica B ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Bioinformatics; Druggable; Extravasation; Inflammation; Intercellular; Protein protein interactions; Proteomics; Target prioritization; Therapeutics

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; NEUTRALIZING ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CELL ACTIVATION; CELL COMMUNICATION AND CELL CONTACT; CELL INTERACTION; CELL SURFACE; COMPUTER PROGRAM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS; T LYMPHOCYTE ACTIVATION;

ANIMALS; CHEMOKINES; COMPUTATIONAL BIOLOGY; HUMANS; LEUKOCYTES; PROTEOMICS;

EID: 84884179762     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-589-7_21     Document Type: Article

References (24)

1. Brown BA (2009) Natalizumab in the treatment of multiple sclerosis. Ther Clin Risk Manag 5:585-594
2. Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F (2012) Tumor necrosis factors blocking agents: analogies and differences. Acta Biomed 83:72-80
3. Perot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO (2010) Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 15:656-667
4. Rossi B, Constantin G (2008) Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm Allergy Drug Targets 7:85-93
5. Engelhardt B, Wolburg H (2004) Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 34:2955-2963
6. Coisne C, Lyck R, Engelhardt B (2007) Therapeutic targeting of leukocyte trafficking across the blood-brain barrier. Inflamm Allergy Drug Targets 6:210-222
7. Wittchen ES (2009) Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci 14:2522-2545
8. Haqqani AS, Stanimirovic DB (2011) Intercellular interactomics of human brain endothelial cells and th17 lymphocytes: a novel strategy for identifying therapeutic targets of CNS inflammation. Cardiovasc Psychiatry Neurol 2011:175364
9. Ransohoff RM (2005) Natalizumab and PML. Nat Neurosci 8:1275
10. Scheinfeld N (2004) A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 15:280-294
11. Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, Bouthillier A, Becher B, Arbour N, David S, Stanimirovic D, Prat A (2008) Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 9:137-145
12. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19:1872-1874
13. Stanimirovic D, Shapiro A, Wong J, Hutchison J, Durkin J (1997) The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion. J Neuroimmunol 76:193-205
14. Haqqani AS, Kelly J, Baumann E, Haseloff RF, Blasig IE, Stanimirovic DB (2007) Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J Proteome Res 6:226-239
15. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173-1175
16. Palagi PM, Walther D, Quadroni M, Catherinet S, Burgess J, Zimmermann-Ivol CG, Sanchez JC, Binz PA, Hochstrasser DF, Appel RD (2005) MSight: an image analysis software for liquid chromatography-mass spectrometry. Proteomics 5:2381-2384
17. Hirosawa M, Hoshida M, Ishikawa M, Toya T (1993) MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 9:161-167
18. Haqqani AS, Kelly JF, Stanimirovic DB (2008) Quantitative protein profiling by mass spectrometry using label-free proteomics. Methods Mol Biol 439:241-256
19. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, Pico AR, Bader GD, Ideker T (2012) A travel guide to Cytoscape plugins. Nat Methods 9:1069-1076
20. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5:101-113
21. Assfalg A, Erdfelder E (2012) CAML-maximum likelihood consensus analysis. Behav Res Methods 44:189-201
22. bi-Haidar A, Kaur J, Maguitman A, Radivojac P, Rechtsteiner A, Verspoor K, Wang Z, Rocha LM (2008) Uncovering protein interaction in abstracts and text using a novel linear model and word proximity networks. Genome Biol 9(Suppl 2):S11
23. Melnik O, Vardi Y, Zhang CH (2004) Mixed group ranks: preference and confidence in classifier combination. IEEE Trans Pattern Anal Mach Intell 26:973-981
24. Haqqani AS, Hill JJ, Mullen J, Stanimirovic D (2011) Methods to study glycoproteins at the blood-brain barrier using mass spectrometry. In: Nag S (ed) Methods in molecular biology: the blood-brain and other neural barriers. The Humana Press, Totowa, NJ, pp 337-353